-
-
-
-
-
-
-
Takeda's zasocitinib beats deucravacitinib in psoriasis study
-
-
-
-
-
-
-
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
-
-
-
-
-
-
-
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) I
-
-
-
-
-
-
74,053 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


